SPI-1005 Treatment in Severe COVID-19 Patients

Clinical trial NCT04483973 · COMPLETED

Trial details

NCT number: NCT04483973
Sponsor: Sound Pharmaceuticals, Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Coronavirus Coronavirus Infection Corona Virus Infection

Start date: 2021-08-27
Primary completion: 2023-05-05
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.